Gretchen A. Jacobson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gretchen A. Jacobson has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- David Blumenthal
Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA
1 shared publication Jae Kim
Department of Surgery, City of Hope National Medical Center, Duarte, CA
1 shared publication- Kevin M. Sullivan
Department of Surgery Louisiana State University Health Sciences Centre New Orleans Louisiana USA
1 shared publication - Mustafa Raoof
Department of Surgery, City of Hope National Medical Center, Duarte, USA
1 shared publication Oliver Eng
Department of Surgery, University of California Irvine, Irvine, CA
1 shared publication- Philip H. G. Ituarte
Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA
1 shared publication
Latest Publications
- 20 February 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (6) , 1239-1249
Medicare Advantage: A Disadvantage for Complex Cancer Surgery Patients
PURPOSE: Nearly half of all Medicare beneficiaries are enrolled in privatized Medicare insurance plans (Medicare Advantage [MA]). Little comparative information is available about access, outcomes, and cost of inpatient cancer surgery between MA and Traditional Medicare (TM) beneficiaries. We set out to assess and compare access, postoperative outcomes, and estimated cost of inpatient cancer surgery among MA and TM beneficiaries.METHODS: Retrospective cohort analysis of MA or TM beneficiaries undergoing elective inpatient cancer surgery (for cancers located in lung, esophagus, stomach, pancreas, liver, colon, or rectum) was performed using the Office of Statewide Health Planning Inpatient Database linked to California Cancer Registry from 2000 to 2020. For each cancer site, risk-standardized access to high-volume hospitals, postoperative 30-day mortality, complications, failure to rescue, and surgery-specific estimated costs were compared between MA and TM beneficiaries.RESULTS: This analysis of 76,655 Medicare beneficiaries (median age 74 years, 51% female, 39% MA) included 31,913 colectomies, 10,358 proctectomies, 4,604 hepatectomies, 2,895 pancreatectomies, 3,639 gastrectomies, 1,555 esophagectomies, and 21,691 lung resections. Except for colon surgery, MA beneficiaries were less likely to receive care at a high-volume hospital. Mortality was significantly higher among MA beneficiaries ( v TM) for gastrectomy (adjusted risk difference [ARD], 1.5%; 95% CI, 0.01 to 2.9; P = .036), pancreatectomy (ARD, 2.0%; CI, 0.80 to 3.3; P = .002), and hepatectomy (ARD, 1.4%; 95% CI, 0.1 to 2.9; P = .04). By contrast, compared with TM, MA beneficiaries incurred lower estimated hospital costs.CONCLUSION: Enrollment in MA plan is associated with lower estimated hospital costs. However, compared with TM, MA beneficiaries had lower access to high-volume hospitals and increased 30-day mortality for stomach, pancreas, or liver surgery.
- 20 February 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (6) , 1239-1249
Medicare Advantage: A Disadvantage for Complex Cancer Surgery Patients
PURPOSE: Nearly half of all Medicare beneficiaries are enrolled in privatized Medicare insurance plans (Medicare Advantage [MA]). Little comparative information is available about access, outcomes, and cost of inpatient cancer surgery between MA and Traditional Medicare (TM) beneficiaries. We set out to assess and compare access, postoperative outcomes, and estimated cost of inpatient cancer surgery among MA and TM beneficiaries.METHODS: Retrospective cohort analysis of MA or TM beneficiaries undergoing elective inpatient cancer surgery (for cancers located in lung, esophagus, stomach, pancreas, liver, colon, or rectum) was performed using the Office of Statewide Health Planning Inpatient Database linked to California Cancer Registry from 2000 to 2020. For each cancer site, risk-standardized access to high-volume hospitals, postoperative 30-day mortality, complications, failure to rescue, and surgery-specific estimated costs were compared between MA and TM beneficiaries.RESULTS: This analysis of 76,655 Medicare beneficiaries (median age 74 years, 51% female, 39% MA) included 31,913 colectomies, 10,358 proctectomies, 4,604 hepatectomies, 2,895 pancreatectomies, 3,639 gastrectomies, 1,555 esophagectomies, and 21,691 lung resections. Except for colon surgery, MA beneficiaries were less likely to receive care at a high-volume hospital. Mortality was significantly higher among MA beneficiaries ( v TM) for gastrectomy (adjusted risk difference [ARD], 1.5%; 95% CI, 0.01 to 2.9; P = .036), pancreatectomy (ARD, 2.0%; CI, 0.80 to 3.3; P = .002), and hepatectomy (ARD, 1.4%; 95% CI, 0.1 to 2.9; P = .04). By contrast, compared with TM, MA beneficiaries incurred lower estimated hospital costs.CONCLUSION: Enrollment in MA plan is associated with lower estimated hospital costs. However, compared with TM, MA beneficiaries had lower access to high-volume hospitals and increased 30-day mortality for stomach, pancreas, or liver surgery.
- Open Access
- 1 August 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (8) , 1169-1170
Putting Medicare Spending for COVID-19 Into Perspective
Tsai and colleagues used Medicare claims data to examine the characteristics and medical spending of older adults diagnosed with COVID-19 from April through December 2020. The editorialists discuss...
- 1 August 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (8) , 1169-1170
Open AccessPutting Medicare Spending for COVID-19 Into Perspective
Tsai and colleagues used Medicare claims data to examine the characteristics and medical spending of older adults diagnosed with COVID-19 from April through December 2020. The editorialists discuss...